NCT05943275

Brief Summary

Follow-up of patients with complex congenital heart disease (CHD) usually involves ultrasound imaging or even MRI or CT scans of the heart and stress testing. But these examinations can be challenged in terms of their sensitivity. Thus, the development of non-invasive jugular venous and radial arterial pressure sensors, reflecting the hemodynamic function of the right heart, would be very useful to the clinician responsible for early detection of a deficit in right ventricular function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 13, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

September 18, 2023

Status Verified

July 1, 2023

Enrollment Period

5 months

First QC Date

June 23, 2023

Last Update Submit

September 15, 2023

Conditions

Keywords

Non-invasive venous pressure measurement

Outcome Measures

Primary Outcomes (1)

  • Estimate the concordance between the mean peak atrial pressure values measured by the two methods (invasive and magnetic sensor) over a 15-minute period.

    Average value of the atrial peak pressure measured by both methods (invasive and magnetic sensor) over a 15-minute period.

    Baseline

Secondary Outcomes (5)

  • Assess whether there is an overlap between the jugular venous pressure curve obtained with a magnetic sensor and the invasive central venous pressure curve

    baseline

  • Assess whether there is an overlap between the jugular venous pressure curve obtained with a magnetic sensor and the invasive central venous pressure curve (atrial filling)

    baseline

  • Assess whether there is an overlap between the jugular venous pressure curve obtained with a magnetic sensor and the invasive central venous pressure curve (Area under the pressure curve during a cardiac revolution)

    baseline

  • Evaluate whether there is an overlap, during a simultaneous measurement, between the jugular venous pressure curve and the radial arterial pressure curve obtained with a magnetic and the radial arterial pressure curve obtained with a magnetic sensor

    baseline

  • To evaluate the safety of measuring jugular venous pressure or radial arterial pressure with a magnetic sensor in patients.

    Baseline

Study Arms (1)

Patient with an indication for right heart catheterization

OTHER

During the preparation of the subject on the cardiac catheterization table, a person specifically trained to the measurements of the medical device under test will be dedicated to this study. Once the skin has been cleaned with alcohol the device (magnet and micro-sensor encapsulated in the plastic support) will be placed on the subject's uninjured skin of the subject, on the path of the jugular vein. A second device will be placed at the level of the radial artery radial artery with the help of a bracelet. The signals will be recorded and observed on a screen for the duration of the invasive hemodynamic measurements, i.e. approximately 15 minutes.

Device: Magnetic sensor

Interventions

During the right heart catheterization procedure, measurement of hemodynamic pressures by the non-invasive experimental method (Magnetic sensor) and the invasive control method

Patient with an indication for right heart catheterization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient who receives a right-sided catheterization
  • Age ≥ 18 years
  • Informed consent

You may not qualify if:

  • Patient with a metal implant near the area of use of the device
  • Pregnant or breastfeeding woman
  • Patient unwilling or unable to sign consent: patient under guardianship or conservatorship, mentally retarded, dementia, language barrier
  • Patient not affiliated to a social security system
  • Patient under court protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Montpellier Département de Cardiologie Hôpital Arnaud de Villeneuve

Montpellier, 34090, France

RECRUITING

Study Officials

  • Quentin DELBAERE, MD

    CHU de Montpellier

    STUDY DIRECTOR

Central Study Contacts

Quentin DELBAERE, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: comparison between two measurement methods, one of which serves as a reference in a single group of patients patients, without randomization, prospective and monocentric. This is a proof-of-concept pilot study. concept.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2023

First Posted

July 13, 2023

Study Start

September 13, 2023

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

September 18, 2023

Record last verified: 2023-07

Locations